Literature DB >> 21523539

Tetrahydroisoquinolines acting as dopaminergic ligands. A molecular modeling study using MD simulations and QM calculations.

Sebastián Andujar1, Fernando Suvire, Inmaculada Berenguer, Nuria Cabedo, Paloma Marín, Laura Moreno, María Dolores Ivorra, Diego Cortes, Ricardo D Enriz.   

Abstract

A molecular modeling study on 16 1-benzyl tetrahydroisoquinolines (BTHIQs) acting as dopaminergic ligands was carried out. By combining molecular dynamics simulations with ab initio and density functional theory (DFT) calculations, a simple and generally applicable procedure to evaluate the binding energies of BTHIQs interacting with the human dopamine D2 receptor (D2 DR) is reported here, providing a clear picture of the binding interactions of BTHIQs from both structural and energetic viewpoints. Molecular aspects of the binding interactions between BTHIQs and the D2 DR are discussed in detail. A significant correlation between binding energies obtained from DFT calculations and experimental pKi values was obtained, predicting the potential dopaminergic effect of non-synthesized BTHIQs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21523539     DOI: 10.1007/s00894-011-1061-0

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  29 in total

1.  Enantioselective syntheses of dopaminergic (R)- and (S)-benzyltetrahydroisoquinolines.

Authors:  N Cabedo; I Andreu; M C Ramírez De Arellano; A Chagraoui; A Serrano; A Bermejo; P Protais; D Cortes
Journal:  J Med Chem       Date:  2001-05-24       Impact factor: 7.446

Review 2.  The Role of histidine residues in low-pH-mediated viral membrane fusion.

Authors:  Thorsten Kampmann; Daniela S Mueller; Alan E Mark; Paul R Young; Bostjan Kobe
Journal:  Structure       Date:  2006-10       Impact factor: 5.006

3.  CoMFA-based prediction of agonist affinities at recombinant wild type versus serine to alanine point mutated D2 dopamine receptors.

Authors:  R E Wilcox; W H Huang; M Y Brusniak; D M Wilcox; R S Pearlman; M M Teeter; C J DuRand; B L Wiens; K A Neve
Journal:  J Med Chem       Date:  2000-08-10       Impact factor: 7.446

4.  Effects of various isoquinoline alkaloids on in vitro 3H-dopamine uptake by rat striatal synaptosomes.

Authors:  P Protais; J Arbaoui; E H Bakkali; A Bermejo; D Cortes
Journal:  J Nat Prod       Date:  1995-10       Impact factor: 4.050

5.  Preparation of dopaminergic N-alkyl-benzyltetrahydroisoquinolines using a 'one-pot' procedure in acid medium.

Authors:  I Andreu; D Cortes; P Protais; B K Cassels; A Chagraoui; N Cabedo
Journal:  Bioorg Med Chem       Date:  2000-05       Impact factor: 3.641

6.  Structural determinants of pharmacological specificity between D(1) and D(2) dopamine receptors.

Authors:  Hongxiang Lan; Curtiss J Durand; Martha M Teeter; Kim A Neve
Journal:  Mol Pharmacol       Date:  2005-10-19       Impact factor: 4.436

7.  Hydrophobic residues of the D2 dopamine receptor are important for binding and signal transduction.

Authors:  W Cho; L P Taylor; A Mansour; H Akil
Journal:  J Neurochem       Date:  1995-11       Impact factor: 5.372

8.  Molecular dynamics simulation of the stability of a 22-residue alpha-helix in water and 30% trifluoroethanol.

Authors:  A R Van Buuren; H J Berendsen
Journal:  Biopolymers       Date:  1993-08       Impact factor: 2.505

9.  1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.

Authors:  Fabrizio Micheli; Giorgio Bonanomi; Frank E Blaney; Simone Braggio; Anna Maria Capelli; Anna Checchia; Ornella Curcuruto; Federica Damiani; Romano Di Fabio; Daniele Donati; Gabriella Gentile; Andy Gribble; Dieter Hamprecht; Giovanna Tedesco; Silvia Terreni; Luca Tarsi; Andrew Lightfoot; Geoff Stemp; Gregor Macdonald; Alex Smith; Michela Pecoraro; Marcella Petrone; Ornella Perini; Jacqui Piner; Tino Rossi; Angela Worby; Maria Pilla; Enzo Valerio; Cristiana Griffante; Manolo Mugnaini; Martyn Wood; Claire Scott; Michela Andreoli; Laurent Lacroix; Adam Schwarz; Alessandro Gozzi; Angelo Bifone; Charles R Ashby; Jim J Hagan; Christian Heidbreder
Journal:  J Med Chem       Date:  2007-09-15       Impact factor: 7.446

10.  Tetrahydroisoquinolines as dopaminergic ligands: 1-Butyl-7-chloro-6-hydroxy-tetrahydroisoquinoline, a new compound with antidepressant-like activity in mice.

Authors:  Inmaculada Berenguer; Noureddine El Aouad; Sebastián Andujar; Vanessa Romero; Fernando Suvire; Thomas Freret; Almudena Bermejo; María Dolores Ivorra; Ricardo D Enriz; Michel Boulouard; Nuria Cabedo; Diego Cortes
Journal:  Bioorg Med Chem       Date:  2009-06-06       Impact factor: 3.641

View more
  3 in total

1.  Tetrahydroisoquinolines functionalized with carbamates as selective ligands of D2 dopamine receptor.

Authors:  Oscar Parravicini; M Lucrecia Bogado; Sebastián Rojas; Emilio L Angelina; Sebastián A Andujar; Lucas J Gutierrez; Nuria Cabedo; M Jesús Sanz; M Pilar López-Gresa; Diego Cortes; Ricardo D Enriz
Journal:  J Mol Model       Date:  2017-09-02       Impact factor: 1.810

2.  Synthesis, Characterization, and Crystal Structure of Some New Tetrahydroisoquinolines and Related Tetrahydrothieno[2,3-c]isoquinolines.

Authors:  Islam S Marae; Etify A Bakhite; Osama S Moustafa; Mohamed S Abbady; Shaaban K Mohamed; Joel T Mague
Journal:  ACS Omega       Date:  2021-03-15

3.  All-Atom Molecular Dynamics Investigations on the Interactions between D2 Subunit Dopamine Receptors and Three 11C-Labeled Radiopharmaceutical Ligands.

Authors:  Sanda Nastasia Moldovean; Diana-Gabriela Timaru; Vasile Chiş
Journal:  Int J Mol Sci       Date:  2022-02-11       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.